Sanofi announces update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study: Paris Friday, February 14, 2025, 12:00 Hrs [IST] A scheduled review of the E.mbrace p ...

The virus struck more layer and other commercial poultry farms, as well as backyard flocks in multiple states.

Market OverviewThe Orphan Drugs Market is a specialized sector within the pharmaceutical industry that focuses on the ...

Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...

Cross-industry collaboration is key to fighting rising costs for consumers. The Fast Company Impact Council is a private ...

Experts discuss South Africa’s current vaccine manufacturing capabilities and the steps needed to prepare for future ...

SinoCellTech (SHA: 688520) has received regulatory approval in China for finotonlimab, making it the first immuno-oncology ...

The Duchenne muscular dystrophy (DMD) market is projected to grow from $2.3 billion in 2023 to $5.2 billion in 2033 across ...

Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...

Highlights,Stratos Wealth Partners LTD. reduced its Sanofi holdings by 10.8% in the fourth quarter.,Institutional investors own 14.04% of Sanofi’s stock.,Market capitalization stands at $137.02 ...

Lenders scheduled a real estate auction for the 1.1 million-square-foot One Lincoln tower in Boston, in the biggest example ...

Wall Street closed mixed on Friday as investors took a breather after a strong week, digesting developments in global trade policy and inflation data. While the Dow Jones Industrial Average dipped ...